CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas
NCT07022964
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
36
Enrollment
OTHER
Sponsor class
Conditions
T-Cell Non-Hodgkin Lymphoma
T-cell Lymphoma (PTCL and CTCL)
Interventions
DRUG:
CD5 CAR-T cells infusion
Sponsor
Beijing GoBroad Hospital
Collaborators
[object Object]
[object Object]